Gene Gulati
About
In The Last Decade
Gene Gulati
37 papers receiving 488 citations
Peers
Comparison fields: 5 of 83
- Physiology 255
- Hematology 105
- Computer Vision and Pattern Recognition 102
- Emergency Medicine 79
- Pulmonary and Respiratory Medicine 65
Countries citing papers authored by Gene Gulati
This map shows the geographic impact of Gene Gulati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gene Gulati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gene Gulati more than expected).
Fields of papers citing papers by Gene Gulati
This network shows the impact of papers produced by Gene Gulati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gene Gulati. The network helps show where Gene Gulati may publish in the future.
Co-authorship network of co-authors of Gene Gulati
This figure shows the co-authorship network connecting the top 25 collaborators of Gene Gulati. A scholar is included among the top collaborators of Gene Gulati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gene Gulati. Gene Gulati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 2 | |
| 3 | 8 | |
| 4 | 0 | |
| 5 | 12 | |
| 6 | 3 | |
| 7 | 76 | |
| 8 | 3 | |
| 9 | 2 | |
| 10 | 10 | |
| 11 | 1 | |
| 12 | 27 | |
| 13 | 6 | |
| 14 | Advances of the past decade in automated hematology. | 15 |
| 15 | 17 | |
| 16 | Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia. | 5 |
| 17 | 23 | |
| 18 | 14 | |
| 19 | 13 | |
| 20 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.